Difference between revisions of "Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5 (Q9620)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: title (P93): PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase, #quickstatements; #temporary_batch_1590010982689)
(‎Created claim: Page(s) (P105): 903-915, #quickstatements; #temporary_batch_1590074839150)
 
Property / Page(s)
 +
903-915
Property / Page(s): 903-915 / rank
 +
Normal rank

Latest revision as of 15:38, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Sancak Y
    0 references
    0 references
    2007
    0 references
    Mol. Cell
    0 references
    25
    0 references
    PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (English)
    0 references
    903-915
    0 references